OmicXHealth
OmicXHealth uses a non-invasive blood test and AI to detect cancer at an earlier stage. It analyzes cell-free DNA methylation patterns using whole-genome bisulfite sequencing and explainable AI to classify samples with OmicXScreen. The platform is cloud-based, enabling scalable analytics and deployment for labs, hospitals, and research institutions, and it focuses on liquid biopsy workflows for early detection. The company plans to expand to multi-cancer detection and to commercialize laboratory-developed test workflows for blood-based classification. The technology aims to improve outcomes by enabling earlier intervention and supports precision healthcare through AI, bioinformatics, and epigenetic data analysis.
OmicXHealth
OmicXHealth uses a non-invasive blood test and AI to detect cancer at an earlier stage. It analyzes cell-free DNA methylation patterns using whole-genome bisulfite sequencing and explainable AI to classify samples with OmicXScreen. The platform is cloud-based, enabling scalable analytics and deployment for labs, hospitals, and research institutions, and it focuses on liquid biopsy workflows for early detection. The company plans to expand to multi-cancer detection and to commercialize laboratory-developed test workflows for blood-based classification. The technology aims to improve outcomes by enabling earlier intervention and supports precision healthcare through AI, bioinformatics, and epigenetic data analysis.